newsfilter
← Latest News
Business Wire·

ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair

ArrePath, a company applying its proprietary artificial intelligence and machine learning platform together with deep R&D technical expertise to address the challenge of best-in-class antibacterial drug discovery,